Christopher A. Kroeger

Christopher A. Kroeger, M.D., a member of our board of directors, is the Chief Executive Officer of Maplight Therapeutics, Inc. Dr. Kroeger is a partner of The Aurora Funds, Inc, and is a director of CardioFocus, Inc. Dr. Kroeger also serves on the board of the Johns Hopkins Technology Alliance and The University of Maryland Baltimore Commercialization Advisory Board. Dr. Kroeger previously was the Chief Executive Officer of Ovascience, Inc. and of Cardioxyl Pharmaceuticals. He served as a director of The Council for Entrepreneurial Development. Dr. Kroeger holds an M.D. degree from Stanford University School of Medicine, an M.B.A. degree from Harvard Business School, and a B.A. degree in Biology from Harvard University.